Trial Profile
Randomized Controlled Trial to determine the efficacy of EVICEL® on blood loss in orthopaedic surgery after total knee replacement (TKR)
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Therapeutic Use
- 14 Sep 2016 New trial record